Excess BMI in childhood: A modifiable risk factor for type 1 diabetes development?

Diabetes Care

Volumn 40, Issue 5, 2017, Pages 698-701

  Ferrara, Christine Therese ^a   Geyer, Susan Michelle ^b   Liu, Yuk Fun ^c   Evans Molina, Carmella ^d   Libman, Ingrid M ^e   Besser, Rachel ^f   Becker, Dorothy J ^e   Rodriguez, Henry ^b   Moran, Antoinette ^g   Gitelman, Stephen E ^a   Redondo, Maria J ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INDIANA UNIVERSITY   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF MINNESOTA   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGE; BODY MASS; CARDIOMETABOLIC RISK; CHILD; CHILDHOOD OBESITY; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL GLUCOSE TOLERANCE TEST; RELATIVE; SEX DIFFERENCE; COMPLICATION; DIABETES MELLITUS, TYPE 1; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; AGE FACTORS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PEDIATRIC OBESITY; RISK FACTORS; SEX FACTORS;

EID: 85019360423     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2331     Document Type: Conference Paper

References (12)

1. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001;44:914-922
2. Elding Larsson H, Vehik K, Haller MJ, et al.; TEDDY Study Group. Growth and risk for islet autoimmunity and progression to type 1 diabetes in early childhood: the Environmental Determinants of Diabetes in the Young Study. Diabetes 2016;65:1988-1995
3. Meah FA, Di Meglio LA, Greenbaum CJ, et al.; Type 1 Diabetes TrialNet Study Group. The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants. Diabetologia 2016;59:1186-1195
4. Kuchlbauer V, Vogel M, Gausche R, et al. High birth weights but not excessive weight gain prior to manifestation are related to earlier onset of diabetes in childhood: 'accelerator hypothesis' revisited. Pediatr Diabetes 2014;15:428-435
5. Sosenko JM, Krischer JP, Palmer JP, et al.; Diabetes Prevention Trial-Type 1 Study Group. A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2008;31:528-533
6. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al.; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of betacell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008;31:1966-1971
7. Sosenko JM, Mahon J, Rafkin L, et al.; Diabetes Prevention Trial-Type 1 and TrialNet Study Groups. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatr Diabetes 2011;12:85-90
8. American Diabetes Association. Standards of medical care in diabetesd2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
9. Skyler JS, Greenbaum CJ, Lachin JM, et al.; Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet-an international collaborative clinical trials network. Ann NYAcad Sci 2008;1150:14-24
10. Lee JM, Gebremariam A, Vijan S, Gurney JG. Excess body mass index-years, a measure of degree and duration of excess weight, and risk for incident diabetes. Arch Pediatr Adolesc Med 2012;166:42-48
11. Bouchard DR, Porneala B, Janssen I, et al. Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. J Diabetes Complications 2013;27:214-218
12. Xu P, Krischer JP; Type 1 Diabetes TrialNet Study Group. Prognostic classification factors associated with development of multiple autoantibodies, dysglycemia, and type 1 diabetesda recursive partitioning analysis. Diabetes Care 2016;39:1036-1044